Literature DB >> 34870691

Omicron Has Reached the US-Here's What Infectious Disease Experts Know About the Variant.

Jennifer Abbasi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34870691     DOI： 10.1001/jama.2021.22619

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  6 in total

Review 1.  SARS-CoV-2 Omicron variant (B.1.1.529): A concern with immune escape.

Authors:  Adekunle Sanyaolu; Aleksandra Marinkovic; Stephanie Prakash; Nafees Haider; Martina Williams; Chuku Okorie; Olanrewaju Badaru; Stella Smith
Journal:  World J Virol       Date:  2022-05-25

2.  Assessment of Neutralizing Antibody Response Against SARS-CoV-2 Variants After 2 to 3 Doses of the BNT162b2 mRNA COVID-19 Vaccine.

Authors:  Koichi Furukawa; Lidya Handayani Tjan; Yukiya Kurahashi; Silvia Sutandhio; Mitsuhiro Nishimura; Jun Arii; Yasuko Mori
Journal:  JAMA Netw Open       Date:  2022-05-02

3.  Omicron variant (B.1.1.529) of SARS-CoV-2: Threat for the elderly?

Authors:  Vivek P Chavda; Vasso Apostolopoulos
Journal:  Maturitas       Date:  2022-01-29       Impact factor: 5.110

4.  A comprehensive analysis of the mutational landscape of the newly emerging Omicron (B.1.1.529) variant and comparison of mutations with VOCs and VOIs.

Authors:  Chiranjib Chakraborty; Manojit Bhattacharya; Ashish Ranjan Sharma; Kuldeep Dhama; Govindasamy Agoramoorthy
Journal:  Geroscience       Date:  2022-08-22       Impact factor: 7.581

Review 5.  Sub-lineages of the SARS-CoV-2 Omicron variants: Characteristics and prevention.

Authors:  Ailan Xu; Bixia Hong; Fuxing Lou; Shuqi Wang; Wenye Li; Amna Shafqat; Xiaoping An; Yunwei Zhao; Lihua Song; Yigang Tong; Huahao Fan
Journal:  MedComm (2020)       Date:  2022-08-16

6.  Excess deaths from COVID-19 among Medicare beneficiaries with psychiatric diagnoses: community versus nursing home.

Authors:  Huiwen Xu; Shuang Li; Hemalkumar B Mehta; Erin L Hommel; James S Goodwin
Journal:  J Am Geriatr Soc       Date:  2022-09-22       Impact factor: 7.538
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.